Private placement

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Friday, September 24, 2021 - 1:00pm

TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross proceeds of CAD$10 million (the “Private Placement”). Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant. Each Warrant will entitle the holder to purchase one Common Share at an exercise price of CAD$0.80 per Common Share and will be immediately exercisable upon issuance for a period of five years following the issuance date.

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
    TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the Company or PharmaTher) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (Common Shares) and warrants to purchase common shares (Warrants) for gross proceeds of CAD$10 million (the Private Placement).
  • Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant.
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the Private Placement.
  • No securities were offered or sold to Canadian residents in connection with the Private Placement.

Aurora Spine Corporation Announces Closing of C$6.5 Million Private Placement with Institutional Investors

Monday, September 20, 2021 - 3:13pm

Pursuant to the Private Placement, the Company has issued 11,220,930 Common Shares and Common Warrants to purchase up to 8,415,697 Common Shares at a combined purchase price of C$0.58 per Common Share and associated Common Warrant.

Key Points: 
  • Pursuant to the Private Placement, the Company has issued 11,220,930 Common Shares and Common Warrants to purchase up to 8,415,697 Common Shares at a combined purchase price of C$0.58 per Common Share and associated Common Warrant.
  • Each Common Warrant entitles the holder thereof to purchase one Common Share at an exercise price of C$0.75 per share at any time prior to the three-year anniversary of the closing date of the Private Placement (the "Closing Date").
  • All necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange, have been received.
  • A.G.P./Alliance Global Partners (the "Agent") acted as the exclusive placement agent for the Private Placement in the United States.

P2 Gold Upsizes Flow-Through Financing

Friday, September 17, 2021 - 11:35pm

VANCOUVER, British Columbia, Sept. 17, 2021 (GLOBE NEWSWIRE) -- (“P2” or the “Company”) (TSX-V:PGLD) reports that it intends to increase the size of its previously announced non-brokered private placement of flow-through shares from up to 1,000,000 flow-through common shares to up to 2,500,000 flow-through common shares in the capital of the Company (the “Private Placement”) that qualify as flow-through shares for purposes of the Income Tax Act (Canada), at a price of $0.50 per common share for gross proceeds of up to $1,250,000.

Key Points: 
  • The Private Placement will be offered to accredited investors in all Provinces of Canada pursuant to applicable securities laws.
  • In connection with the Private Placement, the Company may pay finders fees as permitted by the policies of the Exchange.
  • All securities issued pursuant to the Private Placement will be subject to a four-month hold period.
  • P2 is a mineral exploration and development company focused on advancing precious metals and copper discoveries and acquisitions in the western United States and British Columbia.

DGAP-News: Majorel Group Luxembourg S.A. : Majorel sets indicative price range and starts the offer period for planned private placement ahead of envisaged listing on Euronext Amsterdam

Thursday, September 16, 2021 - 8:04am

This publication constitutes neither an offer to sell nor a solicitation to buy securities.

Key Points: 
  • This publication constitutes neither an offer to sell nor a solicitation to buy securities.
  • This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons.
  • The Underwriters are acting exclusively for Majorel and the selling shareholders and no-one else in connection with the planned Private Placement.
  • 16.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.

Aurora Spine Corporation Announces C$6.5 Million Private Placement with Institutional Investors

Wednesday, September 15, 2021 - 2:25pm

CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has entered into securities purchase agreements for a private placement of the Companys common shares (or common share equivalents) (a Common Share and, collectively, the Common Shares) and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of approximately C$6.5 million (the "Private Placement").

Key Points: 
  • CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (Aurora Spine or the Company) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it has entered into securities purchase agreements for a private placement of the Companys common shares (or common share equivalents) (a Common Share and, collectively, the Common Shares) and warrants to purchase common shares ("Common Warrants") to institutional investors for aggregate gross proceeds to the Company of approximately C$6.5 million (the "Private Placement").
  • A.G.P./Alliance Global Partners (the "Agent") is acting as the exclusive placement agent for the Private Placement in the United States.
  • In addition, the Company will issue to the Agent broker warrants equal to 5.0% of the number of Common Shares sold under the Private Placement ("Broker Warrants").
  • Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Sugarbud Announces Receipt of DTC Eligibility and the Close of a Non-Brokered Private Placement

Wednesday, September 15, 2021 - 12:53am

Securities that are eligible to be electronically cleared and settled through the DTC are considered to be "DTC eligible.

Key Points: 
  • Securities that are eligible to be electronically cleared and settled through the DTC are considered to be "DTC eligible.
  • The Company also announces the completion of a non-brokered private placement (the "Private Placement") for gross proceeds of $355,000, of which executive management and board members took up 74%.
  • Pursuant to the Private Placement, Sugarbud issued 8,875,000 units ("Units") at a price of $0.04 per Unit.
  • Sugarbud will use the proceeds of the Private Placement for general corporate and working capital purposes.

Greenbriar Capital Corp. Closes Oversubscribed Non-Brokered Private Placement

Tuesday, September 14, 2021 - 5:01am

Coquitlam, British Columbia--(Newsfile Corp. - September 14, 2021) - Greenbriar Capital Corp. (TSXV: GRB) (OTC Pink: GEBRF) ("Greenbriar") is pleased to announce that it has closed the non-brokered private placement announced on July 19, 2021 and increased on September 7, 2021.

Key Points: 
  • Coquitlam, British Columbia--(Newsfile Corp. - September 14, 2021) - Greenbriar Capital Corp. (TSXV: GRB) (OTC Pink: GEBRF) ("Greenbriar") is pleased to announce that it has closed the non-brokered private placement announced on July 19, 2021 and increased on September 7, 2021.
  • Greenbriar has issued 878,970 units (the "Units") at a price of $1.65 per Unit for gross proceeds of $1,450,301.
  • Each warrant (a "Warrant") entitles the holder to acquire one additional share in the capital of Greenbriar at a price of $2.00 for a period of two years.
  • Proceeds from the Private Placement will be used by Greenbriar for working capital purposes.

DGAP-News: MustGrow Biologics Arranges $2 Million Equity Private Placement

Monday, September 13, 2021 - 1:20pm

SASKATOON, Saskatchewan, Canada, September 13, 2021 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) ("MustGrow") is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 770,000 units (each a "Unit") for gross proceeds of approximately C$2.0 million at a price per Unit of C$2.60.

Key Points: 
  • SASKATOON, Saskatchewan, Canada, September 13, 2021 - MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) ("MustGrow") is pleased to announce a non-brokered private placement (the "Private Placement") of approximately 770,000 units (each a "Unit") for gross proceeds of approximately C$2.0 million at a price per Unit of C$2.60.
  • The Company intends to use the proceeds from the Private Placement to advance development of its pipeline assets, and for working capital and general corporate purposes.
  • The closing of the Private Placement is scheduled to occur on or about September 28, 2021.
  • All securities issued under the Private Placement will be subject to a hold period expiring 4 months plus 1 day following the closing date of the Private Placement.

Rritual Superfoods Announces Closing of Bought Deal

Friday, September 10, 2021 - 2:15pm

VANCOUVER, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Rritual Superfoods Inc. (“Rritual” or the “Company”) (RSF, RSF.WT) is pleased to announce announced that it has closed its previously announced “bought deal” public offering and raised total gross proceeds of $4,000,000 (the “Offering”).

Key Points: 
  • Each Unit consists of one common share of Rritual (a Common Share) and one-half Common Share purchase warrant.
  • Pursuant to the Offering, Rritual issued an aggregate of 8,000,000 Units at a price of $0.50 per Unit, for total gross proceeds of $4,000,000.
  • Clark Wilson LLP acted as legal counsel to Rritual and Borden Ladner Gervais LLP acted as legal counsel to the Underwriter.
  • Rritual Superfoods is the first award winning, premium brand in the emerging functional mushroom & adaptogenic superfood market.

First Light and New Oroperu's Shareholders Approve Business Combination

Thursday, September 9, 2021 - 6:33pm

Vancouver, British Columbia--(Newsfile Corp. - September 9, 2021) - First Light Capital Corp. (TSXV: XYZ.P) ("First Light") and New Oroperu Resources Inc. (TSXV: ORO) ("New Oroperu") are pleased to announce that the shareholders of both companies have overwhelmingly approved the business combination transaction between them (the "Transaction").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 9, 2021) - First Light Capital Corp. (TSXV: XYZ.P) ("First Light") and New Oroperu Resources Inc. (TSXV: ORO) ("New Oroperu") are pleased to announce that the shareholders of both companies have overwhelmingly approved the business combination transaction between them (the "Transaction").
  • New Oroperu has applied for a final order of the Supreme Court of British Columbia to approve the Arrangement.
  • The completion of the Transaction remains subject to conditions set forth in the Arrangement Agreement, including TSX Venture Exchange approval.
  • For further information, please contact Jim Currie, President and Chief Executive Officer of First Light, at (604) 764-7108.